Grants and Contributions:
Title:
515729
Agreement Number:
515729
Agreement Value:
$880,950.00
Agreement Date:
Nov 29, 2025 - Apr 30, 2026
Description:
Expand adenovirus manufacturing capacity and capabilities, enabling domestic production of larger scale (e.g. Phase II clinical trials) GMP compliant drug product
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
Advance Canada?s scientific, technological and industrial capabilities that can be deployed during health emergencies; and grow and sustain a competitive and innovative life sciences ecosystem that develops the next generation of medicines and technology platforms in Canada.
Location:
Ottawa, Ontario, CA K1Y4E9
Reference Number:
033-2025-2026-Q4-515729
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
886822212
Recipient Type:
Not-for-profit organization or charity
Recipient's Operating Name:
OTTAWA HOSPITAL RESEARCH INSTITUTE
Recipient's Legal Name:
OTTAWA HOSPITAL RESEARCH INSTITUTE
Federal Riding Name:
Ottawa South
Federal Riding Number:
35077
Program:
Life Sciences Fund
Program Purpose:
Misson-driven fund with a dual mandate to advance and strengthen Canada?s scientific, technological and industrial capabilities that can be deployed during health emergencies; and grow and sustain a competitive and innovative life sciences ecosystem that develops the next generation of medicines and technology platforms in Canada.
NAICS Code:
621510